← All solutionsPharma & health

Track every dose.
Stop diversion before it ships.

Serialization is a baseline — verification is the bar. PRVNZ extends DSCSA and EU FMD with cryptographic proof and AI diversion detection.

What you ship

The PRVNZ stack, configured for pharma & health.

  • Unit-level serialization at scale
  • Diversion and gray-market detection
  • Patient-facing authenticity scan
  • Cold-chain and recall workflows

Regulations in scope

Every law that touches pharma & health.

ESPR / EU 2024/1781

EU Digital Product Passport

The first universal product passport.

Under the Ecodesign for Sustainable Products Regulation (entered into force July 18, 2024), products placed on the EU market will progressively require a Digital Product Passport — sector by sector — through delegated acts. The passport links a unique product identifier to verifiable information about composition, origin, repair, recycling, and environmental footprint, accessible to consumers, repairers, recyclers, customs, and market surveillance.

Read the alignment
EU 2023/1542

EU Battery Regulation

The first ESPR sector to ship at scale.

Every electric-vehicle and industrial battery placed on the EU market after February 18, 2027 must carry a digital Battery Passport — a QR-accessible record of performance, durability, chemistry, recycled content, carbon footprint, and ownership history. The first sector-wide DPP and the template every other industry will follow.

Read the alignment
Other regulations to watch:US DSCSAEU FMD 2011/62/EUEU MDR 2017/745

See PRVNZ inside a pharma & health brand.

Book a walkthrough